Data / Form D filings / Opus KSD, Inc.
Opus KSD, Inc.: Form D filing
Opus KSD, Inc., a biotechnology company in Pembroke, MA, filed a Form D with the SEC in 2026. The latest, on October 1, 2026, reports $680,801 sold of a $680,801 offering to 16 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 50 Corporate Park Dr. Suite 710, Pembroke, MA, 02359
- Phone
- (781) 929-7406
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1668934
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Oct 1 | New notice | $680,801 | $680,801 | 16 | Sep 23 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Charles Rogers | Director | |
| Saud Alturki | Director | |
| Porter Anderson | Director | |
| Kenneth Danielson | Director | |
| Christos Monovoukas | Director | |
| Wei Shen | Director |
Other biotechnology companies in Massachusetts that filed recently
- LeanBio Therapeutics, Inc. offering · Oct 22
- Quiver Holdings Inc. $3 million · Oct 21
- Axelyf, Inc. $2.6 million · Oct 13
- BIOVENTRIX, INC. $1.2 million · Oct 8
Every Form D from the week of Sep 28 · All recent filings in Massachusetts · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Opus KSD, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.